| Place of Origin: | China |
|---|---|
| Brand Name: | Senwayer Brand |
| Certification: | ISO, 9001, USP |
| Model Number: | 95058-81-4 |
| Minimum Order Quantity: | 10grams |
| Price: | Discount is possible if your order is big enough |
| Packaging Details: | 10g, 20g, 50g , 100g, 500g. 1kg, 10kg |
| Delivery Time: | within 2 working days |
| Payment Terms: | T/T in advance, Money Gram, Western Union, Bank Transfer. |
| Supply Ability: | 1000kg/month |
| CAS: | 95058-81-4 | Apparence: | White Crystalline Powder |
|---|---|---|---|
| Purity: | 99% | Other Name: | Gencitabine Base |
| MF: | C9H11F2N3O4 | MW: | 263.2 |
| EINECS: | 619-100-6 | Usage: | API |
| High Light: | anti cancer drugs,breast cancer drugs |
||
Gemcitabine CAS 95058-81-4 Healthy Antineoplastic Raw Material Drug White Powder
Quick detail
| Name: | Gemcitabine |
| CAS No.: | 95058-81-4 |
| Formula: | C9H11F2N3O4 |
| Molecular Weight: | 263.23 |
| Synonyms: | 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;Cytidine, 2-deoxy-2,2-difluoro-2-Deoxy-.beta.-D-2,2-difluorocytidine;Gemcitabine [USAN:BAN:INN];DDFC;LY 188011;LY188011 hydrochloride;Cytosine, 1-(2-deoxy-2,2-difluoro-beta-D-erythro-pentofuranosyl)-;Gemcitabine hydrochloride [USAN];LY188011;2-Deoxy-2,2-difluorocytidine monohydrochloride;Gemzar;2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-2,2-difluoro-D-erythro-pentofuranosyl)-;2'-Deoxy-2',2'-Difluorocytidine;2',2'-Difluorodeoxycytidine(Gemcitabine base);Cytidine, 2'-deoxy-2',2'-difluoro-; |
| Density: | 1.84 g/cm3 |
| Melting Point: | 168.64 °C |
| Boiling Point: | 482.7 °C at 760 mmHg |
| Flash Point: | 245.7 °C |
| Appearance: | white powder |
Gemcitabine Description:
Gemcitabine (2’,2’-difluorodeoxycytidine; dFdCyd) is a novel deoxycytidine analogue with both structural and metabolic similarities to cytarabine. It has a broad spectrum of antitumor activity in preclinical murine leukemia and solid tumor models. This drug requires intracellular phosphorylation that results in the accumulation of difluorodeoxycytidine triphosphate (dFdCTP). The dFdCTP competes with deoxycytidine triphosphate (dCTP) for incorporation into DNA, which in turn inhibits DNA synthesis and terminates DNA chain elongation. In addition, this drug reduces intracellular deoxynucleoside triphosphate pools, presumably through the inhibition of ribonucleotide reductase.
Gemcitabine Usage
| Usage 1 |
Gemcitabine(Gemzar) belongs to the group of medicines called antimetabolites.
|
| Usage 2 |
It is used alone or in combination with other medicines to treat cancer of the breast, ovary, pancreas, and lung.
|
| Usage 3 | Gemcitabine interferes with the growth of cancer cells. |
| Usage 4 |
Gemcitabine is used alone or with other treatments/medications to treat certain types of cancer (including breast cancer, non-small cell lung cancer, ovarian cancer, pancreatic cancer, bladder cancer, bone cancer, Ewing’s sarcoma, mesenchymal chondrosarcoma osteosarcoma, dedifferentiated chondrosarcoma, head and neck cancers-cancer of the nasopharynx, hepatobiliary cancers including gallbladder cancer, Hodgkin lymphoma, kidney cancer, malignant pleural mesothelioma, non Hodgkin lymphoma, non-melanoma skin cancer – dermatofibrosarcoma protuberans (DFSP), occult primary, small cell lung cancer, soft tissue sarcoma, testicular cancer, thymic malignancies, uterine malignancies).
|
| Usage 5 |
It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells. One commercial product of gemcitabine is Gemzar, which is supplied in a sterile form for intravenous use only.
|
